This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Ghent. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Hans Verstraelen: Innovator in Intravaginal Delivery Systems
Introduction
Hans Verstraelen is a notable inventor based in Merelbeke, Belgium. He has made significant contributions to the field of medical technology, particularly in the development of innovative delivery systems. His work focuses on enhancing the effectiveness of drug delivery methods, which can have a profound impact on patient care.
Latest Patents
Hans Verstraelen holds a patent for an intravaginal delivery system. This invention relates to a system designed for the controlled release of one or more organic acids, such as lactic acid. The system is characterized by a combination of ethylene vinyl acetate (EVA) copolymers and carboxylic polymers, such as methacrylic acid-methacrylic ester copolymers. This innovative approach aims to improve the efficacy and safety of intravaginal drug delivery.
Career Highlights
Hans Verstraelen is affiliated with the University of Ghent, where he continues to advance his research in drug delivery systems. His academic background and ongoing research contribute to the development of new technologies that can enhance therapeutic outcomes. With a focus on practical applications, his work is paving the way for future innovations in the medical field.
Collaborations
Hans has collaborated with esteemed colleagues, including Jean Paul Remon and Chris Vervaet. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of research and innovation.
Conclusion
Hans Verstraelen is a pioneering inventor whose work in intravaginal delivery systems exemplifies the intersection of innovation and healthcare. His contributions are vital in advancing medical technology and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
